Skip to main content

Animations

MJFF Publications

4931 - 4940 of 6509 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2021
  • 2023
  • 2022
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Sources of PM2.5 exposure misclassification in three Finnish register-based study populations and the impact on attenuation of health effect estimates
    Journal Name: Science of The Total Environment
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.scitotenv.2024.176422
    Citation Count: 6
  • Summary Details
    OPEN
    Title: An immersive virtual reality shopping task detects declines in instrumental activities of daily living in individuals with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107019
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Targeting short-chain fatty acids receptors signalling for neurological disorders treatment
    Journal Name: Exploration of Neuroprotective Therapy
    Publisher: Open Exploration Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.37349/ent.2024.00073
    Citation Count: 8
  • Summary Details
    OPEN
    Title: The commercial genetic testing landscape for Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.001
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.scr.2023.103125
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100661
    Citation Count: 159
  • Summary Details
    OPEN
    Title: Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awae069
    Citation Count: 38
  • Summary Details
    OPEN
    Title: CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-023-00627-5
    Citation Count: 58
  • Summary Details
    OPEN
    Title: A leaky gut dysregulates gene networks in the brain associated with immune activation, oxidative stress, and myelination in a mouse model of colitis
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbi.2024.02.007
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha‐synuclein levels in Lewy body disease
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/nan.12999
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.